No Prescription Needed—FDA Gives Gland’s Vizag Plant a Clean Bill of Health

Unknown Apr 02, 2026 1,000 Views

Gland Pharma Ltd (NSE: GLAND.NS) received an Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (US FDA) at the company's JNPC facility in Visakhapatnam, Andhra Pradesh. The EIR is a confirmation of the satisfactory execution of a Pre-Approval Inspection (PAI) be...